{"id":"nutriflex-omega-special-oxepa","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypertriglyceridemia"},{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Hepatic dysfunction"},{"rate":null,"effect":"Infusion site reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Nutriflex Omega special is a lipid emulsion-based parenteral nutrition containing omega-3 and omega-6 polyunsaturated fatty acids designed to support immune function and reduce inflammation. Oxepa is an enteral/parenteral nutrition product enriched with eicosapentaenoic acid (EPA), gamma-linolenic acid (GLA), and antioxidants to modulate the inflammatory response in acute respiratory distress syndrome and critical illness.","oneSentence":"Nutriflex Omega special + Oxepa is a parenteral nutrition formulation that provides essential fatty acids, amino acids, and micronutrients to support metabolic function and reduce inflammatory markers in critically ill patients.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:23:39.464Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Nutritional support in critically ill patients"},{"name":"Acute respiratory distress syndrome (ARDS)"},{"name":"Sepsis and systemic inflammatory response"}]},"trialDetails":[{"nctId":"NCT01162928","phase":"PHASE3","title":"Parenteral Nutrition With Intravenous and Oral Fish Oil for Intensive Care Patients","status":"COMPLETED","sponsor":"B. Braun Melsungen AG","startDate":"2013-05","conditions":"Critical Illness","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Nutriflex Omega special + Oxepa","genericName":"Nutriflex Omega special + Oxepa","companyName":"B. Braun Melsungen AG","companyId":"b-braun-melsungen-ag","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Nutriflex Omega special + Oxepa is a parenteral nutrition formulation that provides essential fatty acids, amino acids, and micronutrients to support metabolic function and reduce inflammatory markers in critically ill patients. Used for Nutritional support in critically ill patients, Acute respiratory distress syndrome (ARDS), Sepsis and systemic inflammatory response.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}